1. Gutterman DD. Silent myocardial ischemia. Circulation j 2009; 73(5): 785-97.
2. Hatmi Z, Tahvildari S, Motlag AG, Kashani AS. Prevalence of coronary artery disease risk factors in Iran: a population based survey. BMC Cardiovascular Disorders 2007; 7(1): 32.
3. Sittiwicheanwong R, Ariyapitipun T, Gulsatitporn S, Nopponpunth V, Abeywardena M, et al. Alterations of atherogenic low-density lipoproteins and serum fatty acids after 12 week moderate exercise training in sedentary Thai women. Asia Pacific j clinical nutrition 2007; 16(4): 602-8.
4. Ferdinandy P, Schulz R, Baxter GF. Interaction of cardiovascular risk factors with myocardial ischemia/reperfusion injury, preconditioning, and postconditioning. Pharmacological Reviews 2007; 59|: 418-58.
5. Powers SK, Sollanek KJ, Wiggs MP, Demirel HA, Smuder AJ. Exercise-induced improvements in myocardial antioxidant capacity: the antioxidant players and cardioprotection. Free radical res 2014; 48(1): 43-51.
6. Calvert JW, Condit ME, Aragón JP, Nicholson CK, Moody BF, Hood RL, et al. Exercise protects against myocardial ischemia–reperfusion injury via stimulation of β3-adrenergic receptors and increased nitric oxide signaling: role of nitrite and nitrosothiols. Circulation res 2011; 108(12): 1448-58.
7. Hull S, Vanoli E, Adamson PB, Verrier RL, Foreman RD, Schwartz PJ. Exercise training confers anticipatory protection from sudden death during acute myocardial ischemia. Circulation 1994; 89(2): 548-52.
8. Shephard RJ, Balady GJ. Exercise as cardiovascular therapy. Circulation 1999; 99(7): 963-72.
9. Cohen MV, Downey JM. Ischemic preconditioning: description, mechanism, and significance. Heart physiology and pathophysiology, 4th edn. Academic Press, San Diego 2001; 867-85.
10. Das S, Alagappan VK, Bagchi D, Sharma HS, Maulik N, Das DK. Coordinated induction of iNOS–VEGF–KDR–eNOS after resveratrol consumption: A potential mechanism for resveratrol preconditioning of the heart. Vascular pharmacology 2005; 42: 281-89.
11. Nounou HA, Deif MM, & Shalaby MA. Effect of flaxseed supplementation and exercise training on lipid profile, oxidative stress and inflammation in rats with myocardial ischemia. Lipids Health Dis 2012; 11(1): 129.
12. Ahn J, Cho I, Kim S, Kwon D, Ha T. Dietary resveratrol alters lipid metabolism-related gene expression of mice on an atherogenic diet. J hepatology 2008; 49: 1019-28.
13. Afshin S, Mohammadi M, Vatankhah A, Alvandian E, Badalzadeh R, Mohaddes G , et al. Effect of Treadmill Exercise and Diosgenin on Biochemical Alterations in Isoproterenol-Induced Myocardial Infarction in Rats. Pharmaceutical Sci 2009; 15(1): 23- 30. [persion]
14. Hashemian M, Shabestari M, Jabari AF, Azizi H, The role of glucose-insulin-potassium therapy in the treatment of acute myocardial infarction: A review article. Journal of Sabzevar University of Medical Sciences 2012; 65: 206-16. [persion]
15. Dolinsky VW, Rogan KJ, Sung MM, Zordoky BN, Haykowsky MJ, Young ME & et al. Both aerobic exercise and resveratrol supplementation attenuate doxorubicin-induced cardiac injury in mice. American J Physiology-Endocrinology and Metabolism 2013; 305(2): 243-53.
16. Lippincott Williams & Wilkins, ACSM's guidelines for exercise testing and prescription. Medicine; 2013.
17. Lobo Filho HG, Ferreira NL, Sousa RBd, Carvalho ERd, Lobo PLD, Lobo Filho JG. Experimental model of myocardial infarction induced by isoproterenol in rats. Revista Brasileira de Cirurgia Cardiovascular 2011; 26: 469-76.
18. Friedewald Wt, Levy Ri & Fredrickson Ds. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clinical chemistry 1972; 18: 499-502.
19. Zaafan Ma, Zaki Hf, El-Brairy Ai, Kenawy Sa. Protective effects of atorvastatin and quercetin on isoprenaline-induced myocardial infarction in rats. Bulletin of Faculty of Pharmacy, Cairo University 2013; 51: 35-41.
20. Tome-Carneiro J, Gonzálvez M, Larrosa M, Yáñez-Gascón Mj, García-Almagro Fj, Ruiz-Ros Ja, et al. Grape resveratrol increases serum adiponectin and downregulates inflammatory genes in peripheral blood mononuclear cells: a triple-blind, placebo-controlled, one-year clinical trial in patients with stable coronary artery disease. Cardiovascular Drugs and Therapy 2013; 27: 37-48.
21. El-Mowafy A, El-Mesery M, Salem H, Al-Gayyar M & Darweish M. Prominent chemopreventive and chemoenhancing effects for resveratrol: unraveling molecular targets and the role of C-reactive protein. Chemotherapy 2010; 56: 60-65.
22. Timmers S, Konings E, Bilet L, Houtkooper Rh, Van De Weijer T, Goossens Gh, et al. Calorie restriction-like effects of 30 days of resveratrol supplementation on energy metabolism and metabolic profile in obese humans. Cell metabolism 2011; 14, 612-22.
23. Bo S, Ciccone G, Castiglione A, Gambino R, De Michieli F, Villois P, et al. Anti-inflammatory and antioxidant effects of resveratrol in healthy smokers a randomized, double-blind, placebo-controlled, cross-over trial. Current medicinal chemistry 2013; 20: 1323-31.
24. JIANG WJ. Sirtuins: novel targets for metabolic disease in drug development. Biochemical and biophysical res communications 2008; 373: 341-44.
25. Csiszar A, Labinskyy N, Podlutsky A, Kaminski Pm, Wolin Ms, Zhang C , et al. Vasoprotective effects of resveratrol and SIRT1: attenuation of cigarette smoke-induced oxidative stress and proinflammatory phenotypic alterations. American J Physiology-Heart and Circulatory Physiology 2008; 294: 2721-35.
26. Ungvari Z, Orosz Z, Rivera A, Labinskyy N, Xiangmin Z, Olson S & Et Al. Resveratrol increases vascular oxidative stress resistance. American J Physiology-Heart and Circulatory Physiology 2007; 292: 2417-24.
27. Miller Nj, Rice-Evans C ,Davies Mj, Gopinathan V & Milner A. A novel method for measuring antioxidant capacity and its application to monitoring the antioxidant status in premature neonates. Clinical sci 1993; 84: 407-8.
28. Paritha I. & Shyamala D. Effect of alpha-tocopherol on isoproterenol-induced changes in lipid and lipoprotein profile in rats. Indian journal of pharmacology 1997; 29: 399.
29. Fruchart Jc, Staels B & Duriez P. PPAR-alpha in lipid and lipoprotein metabolism, vascular inflammation and atherosclerosis. Atherosclerosis, Hypertension and Diabetes 2011; 8: 3-16.
30. Brownsey Rw, Boone An, Elliott Je, Kulpa Je, Lee Wm. Regulation of acetyl-CoA carboxylase. Biochem Soc Trans 2006; 34(2): 223-7.